Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Imunon, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +5 vs. Q2 2024
- Shares held
- 1.02M
- +701.3K (+222.8%) vs. Q2 2024
- Total value
- $1.08M
- +$702.4K (+187.6%) vs. Q2 2024
- New holders
- 8
- 3 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 608,203 | $644.7K | 8.93% | +608,203 | New |
| Geode Capital Management, LLC | 125,935 | $133.5K | 0.00% | +51,282+68.7% | Added |
| Renaissance Technologies LLC | 63,611 | $67.4K | 0.00% | −47,700−42.9% | Reduced |
| BlackRock, Inc. | 58,222 | $61.7K | 0.00% | +58,222 | New |
| Vanguard Group Inc | 48,806 | $51.7K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 33,985 | $36.0K | 0.00% | +33,985 | New |
| State Street Corp | 21,303 | $22.6K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 15,169 | $16.0K | 0.00% | +15,169 | New |
| Jane Street Group, LLC | 12,503 | $13.3K | 0.00% | +12,503 | New |
| Two Sigma Securities, LLC | 10,521 | $11.2K | 0.00% | +10,521 | New |
| Nations Financial Group Inc, | 10,000 | $10.6K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 4,889 | $5.18K | 0.00% | −3,485−41.6% | Reduced |
| Morgan Stanley | 2,131 | $2.26K | 0.00% | +500+30.7% | Added |
| M&R Capital Management Inc | 333 | $353 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 129 | $137 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 118 | $125 | 0.00% | +41+53.2% | Added |
| Federation des caisses Desjardins du Quebec | 66 | $70 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 21 | $22 | 0.00% | −12,956−99.8% | Reduced |
| Jones Financial Companies LLLP | 5 | $5 | 0.00% | +5 | New |
| Advisor Group Holdings, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Colony Group, LLC | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Caitlin John, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |